Neotame vs High-Fructose Corn Syrup: which is worse?

What is Neotame?

Neotame is a synthetic dipeptide sweetener — a derivative of aspartame with a 3,3-dimethylbutyl group added to block aspartame's metabolism, preventing the release of phenylalanine. This means it is safe for people with phenylketonuria (PKU), unlike aspartame. It is approximately 7,000-13,000 times sweeter than sucrose.

What is High-Fructose Corn Syrup?

High-fructose corn syrup (HFCS) is a liquid sweetener produced by enzymatically converting a portion of corn syrup's glucose to fructose. The most common forms are HFCS-55 (55% fructose, 45% glucose, used primarily in beverages) and HFCS-42 (42% fructose, used in processed foods). It became dominant in the US food supply in the 1970s-1980s.

Documented risks

Neotame: Neotame is one of the newer synthetic sweeteners with a shorter safety track record. A 2023 study published in Frontiers in Nutrition found that neotame damaged intestinal epithelial cells in vitro and disrupted the gut microbiome in mice — including reducing beneficial bacteria and increasing bacterial invasion of intestinal cells. The study observed effects at concentrations that could be achievable through high consumption of neotame-containing products. The FDA has set an ADI of 0.3 mg/kg/day, one of the lower sweetener ADIs, reflecting a conservative safety margin. Limited long-term human safety data exist compared to aspartame, acesulfame K, or saccharin, which have been used for decades. EFSA's 2010 opinion found no safety concern at permitted levels. The Frontiers in Nutrition 2023 gut study represents new concerning findings that warrant further investigation.

High-Fructose Corn Syrup: HFCS has been at the center of one of nutrition science's most contentious debates for 30+ years. The core concern is that fructose is metabolized differently than glucose: fructose is processed primarily in the liver where it can be converted to fat (de novo lipogenesis), contributing to non-alcoholic fatty liver disease (NAFLD) and elevated triglycerides. A landmark 2004 paper by Bray, Nielsen, and Popkin in the American Journal of Clinical Nutrition proposed that the increase in HFCS consumption from the 1970s tracked with rising obesity rates. This hypothesis was widely publicized but contested; subsequent controlled research found that HFCS and sucrose produce similar metabolic effects calorie-for-calorie. However, the broader research on fructose metabolism supports metabolic concerns. A 2012 PLOS ONE study (Basu et al.) found higher sugar-sweetened beverage consumption associated with increased rates of metabolic syndrome and type 2 diabetes. A 2012 Nature commentary by Lustig, Schmidt, and Brindis ('The Toxic Truth About Sugar') argued fructose's hepatic metabolism makes it uniquely harmful — prompting significant scientific debate. Key established effects of high fructose intake include: increased visceral fat, elevated blood triglycerides, increased uric acid (gout risk), worsened insulin resistance, and accelerated NAFLD progression. These effects occur with high fructose intake from any source (HFCS or sucrose), making HFCS no inherently worse than sucrose at equivalent doses — but its ubiquity in US processed foods contributes to chronically elevated fructose exposure at a population level. Mercury contamination: in 2009, independent testing by the Institute for Agriculture and Trade Policy (IATP) and a study in Environmental Health found mercury traces in some HFCS samples from certain manufacturers using mercury-grade caustic soda. The industry has largely transitioned to mercury-free processing since these findings.